3 ASX 200 stocks storming higher this week on big news

These three ASX 200 stocks surged 17% to 23% this week following big announcements.

With just a few hours left before the end of trade on Friday, the S&P/ASX 200 Index (ASX: XJO) is up 3.1% for the week, with these three ASX 200 stocks racing ahead of those gains.

Here's what's been piquing investor interest this week.

Three trophies in declining sizes with a red curtain backdrop.

Image source: Getty Images

Westgold Resources Ltd (ASX: WGX)

At time of writing Westgold shares are changing hands for $5.59 apiece, putting this ASX 200 stock up 18.2% for the week.

The Aussie gold miner got a big boost on Wednesday, after announcing it was increasing the processing capacity at its Western Australian Cue processing hub from 1.4 million tonnes per annum (Mtpa) to 1.7 Mtpa by FY 2028, representing a 21% boost.

The miner expects this will enable it to increase gold production by some 15,000 ounces per year.

"Bigger mines need bigger mills," Westgold CEO Wayne Bramwell said.

He added:

This simple upgrade and modest capital investment at the Cue hub reflects a deliberate shift towards processing hub optimisation and expansion, with lower operating costs and higher cashflow the objective.

Pinnacle Investment Management Group Ltd (ASX: PNI)

The second ASX 200 stock storming higher on big news this week is financial services company Pinnacle Investment.

Pinnacle shares are currently trading for $18.74 each, up 17.3% since last Friday's close.

Investors bid up the Pinnacle share price following on the company's full year FY 2026 results release on Tuesday.

Highlights included a 28% year on year increase in aggregate funds under management (FUM) to $229.4 billion. That was supported by record net inflows of $33.4 billion, including retail and international inflows.

On the bottom line, Pinnacle shares got caught tailwinds with the company reporting FY 2026 underlying net profit after tax (NPAT) of $138.0 million, up 21%.

Commenting on the results, Pinnacle CEO Ian Macoun said:

We continue to build Pinnacle to deliver sustained high rates of growth for many years into the future. Our distinct business model and Three Horizons growth strategy have built a highly diversified platform across asset classes, geographies and product formats.

Which brings us to…

Neuren Pharmaceuticals Ltd (ASX: NEU)

Neuren shares are currently trading at $22.39, which sees this ASX 200 stock up an impressive 24.2% for the week.

Shares in the ASX 200 biopharmaceutical company closed up 16.3% on Wednesday following the release of Neuren's second quarter (Q2 2026) update.

Investors were piling into the stock, with Neuren reporting a 24% quarter-on-quarter increase in net sales from its patented prescription drug DAYBUE to US$125 million.

This saw full calendar year 2026 DAYBUE net sales guidance increased to the range of US$480 to US$510 million.

"We are pleased to see an exceptional quarter for DAYBUE, with very strong sales volume growth reflecting the early success of [DAYBUE] STIX in the US," Neuren CEO Jon Pilcher said.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Pinnacle Investment Management Group. The Motley Fool Australia has positions in and has recommended Pinnacle Investment Management Group. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ASX Share Market News

Happy wife holding her hands on her husband's shoulders while both look at a laptop.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

A man stands in front of a chart with an arrow going down and slaps his forehead in frustration.
ASX Share Market News

ASX 200 mining shares smashed in major market sell-off

The ASX 200 fell 5.39% amid a mining sell-off, with BHP shares tumbling almost 13% last week.

Read more »

A woman weraing a stripy t-shirt winks as she points to the decorative gold crown on her head.
ASX Share Market News

CBA shares back on top of the ASX 200 as BHP dives 13% this week

CBA shares have rallied 9.5% over the past month whilst BHP tumbled 13% this week.

Read more »

a man wearing a hard hat and a high visibility vest stands with his arms crossed in front of heavy equipment at a mine site.
Broker Notes

BHP share price drops 13% to seven-month low in just 1 week. Do experts say buy?

Market analysts offer their advice as BHP shares plunge this week.

Read more »

A distressed young woman reads bad news on her smartphone while standing in a modern indoor setting.
Broker Notes

5 ASX 200 shares experts recommend we buy amid the market carnage this week

ASX 200 shares are down 5.2% this week and back in the red for 2026 overall.

Read more »

Comical investor reading documents and surrounded by calculators.
Broker Notes

Buy, hold, sell: Hub24, Reece, Ramsay Healthcare shares

Analysts reveal their ratings on this financial services provider, plumbing supplies company, and private hospital operator.

Read more »

IPO spelt out on a laptop with a red and green bar chart underneath.
IPOs

Anthropic hits the market. Was it enough to distract investors from a bruised AI sector and Nvidia's scandal?

Was the biggest IPO in US history enough to re-energise the AI trade?

Read more »

A man with his back to the camera holds his hands to his head as he looks to a jagged red line trending sharply downward.
Broker Notes

Three of the worst performers in the ASX 200. Brokers think they're ready to bounce back

There could be a lot of value in these poor performers.

Read more »